COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CHCT • US20369C1062

18.14 USD
+0.1 (+0.55%)
At close: Feb 5, 2026
18.14 USD
0 (0%)
After Hours: 2/5/2026, 7:15:50 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHCT. CHCT was compared to 124 industry peers in the Diversified REITs industry. CHCT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CHCT is valued expensive at the moment. Finally CHCT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CHCT has reported negative net income.
  • CHCT had a positive operating cash flow in the past year.
  • Of the past 5 years CHCT 4 years were profitable.
  • Each year in the past 5 years CHCT had a positive operating cash flow.
CHCT Yearly Net Income VS EBIT VS OCF VS FCFCHCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • CHCT has a Return On Assets of -1.06%. This is in the lower half of the industry: CHCT underperforms 67.74% of its industry peers.
  • CHCT has a worse Return On Equity (-2.46%) than 66.94% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.27%, CHCT is in line with its industry, outperforming 42.74% of the companies in the same industry.
  • CHCT had an Average Return On Invested Capital over the past 3 years of 2.59%. This is in line with the industry average of 3.05%.
Industry RankSector Rank
ROA -1.06%
ROE -2.46%
ROIC 2.27%
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
CHCT Yearly ROA, ROE, ROICCHCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3 4

1.3 Margins

  • The Operating Margin of CHCT (23.26%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CHCT has declined.
  • Looking at the Gross Margin, with a value of 80.68%, CHCT belongs to the top of the industry, outperforming 81.45% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CHCT has remained more or less at the same level.
Industry RankSector Rank
OM 23.26%
PM (TTM) N/A
GM 80.68%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
CHCT Yearly Profit, Operating, Gross MarginsCHCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHCT is destroying value.
  • CHCT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CHCT has been increased compared to 5 years ago.
  • CHCT has a worse debt/assets ratio than last year.
CHCT Yearly Shares OutstandingCHCT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHCT Yearly Total Debt VS Total AssetsCHCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CHCT has an Altman-Z score of 0.86. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 0.86, CHCT is doing good in the industry, outperforming 66.94% of the companies in the same industry.
  • A Debt/Equity ratio of 1.25 is on the high side and indicates that CHCT has dependencies on debt financing.
  • CHCT has a Debt to Equity ratio (1.25) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACC0.33
WACC6.8%
CHCT Yearly LT Debt VS Equity VS FCFCHCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • CHCT has a Current Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CHCT has a Current ratio of 0.47. This is amonst the worse of the industry: CHCT underperforms 80.65% of its industry peers.
  • A Quick Ratio of 0.16 indicates that CHCT may have some problems paying its short term obligations.
  • CHCT has a Quick ratio of 0.16. This is amonst the worse of the industry: CHCT underperforms 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.16
CHCT Yearly Current Assets VS Current LiabilitesCHCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for CHCT have decreased strongly by -146.88% in the last year.
  • CHCT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.22% yearly.
  • Looking at the last year, CHCT shows a very negative growth in Revenue. The Revenue has decreased by -17.52% in the last year.
  • CHCT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.73% yearly.
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 42.04% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CHCT will show a quite strong growth in Revenue. The Revenue will grow by 9.35% on average per year.
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue Next Year5.07%
Revenue Next 2Y5.72%
Revenue Next 3Y6.67%
Revenue Next 5Y9.35%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHCT Yearly Revenue VS EstimatesCHCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
CHCT Yearly EPS VS EstimatesCHCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • CHCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 37.84, CHCT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CHCT indicates a somewhat cheap valuation: CHCT is cheaper than 69.35% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.20, CHCT is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 37.84
CHCT Price Earnings VS Forward Price EarningsCHCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • CHCT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.63
CHCT Per share dataCHCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CHCT's earnings are expected to grow with 42.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.09%
EPS Next 3Y42.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • CHCT has a Yearly Dividend Yield of 11.14%, which is a nice return.
  • Compared to an average industry Dividend Yield of 6.98, CHCT pays a better dividend. On top of this CHCT pays more dividend than 95.97% of the companies listed in the same industry.
  • CHCT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 11.14%

5.2 History

  • The dividend of CHCT has a limited annual growth rate of 2.99%.
  • CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As CHCT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
CHCT Yearly Dividends per shareCHCT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • The earnings of CHCT are negative and hence is the payout ratio. CHCT will probably not be able to sustain this dividend level.
  • CHCT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-507.68%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
CHCT Yearly Income VS Free CF VS DividendCHCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

More info and screens

Find the best dividend stocksShow peers with best dividend

COMMUNITY HEALTHCARE TRUST I

NYSE:CHCT (2/5/2026, 7:15:50 PM)

After market: 18.14 0 (0%)

18.14

+0.1 (+0.55%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-28
Earnings (Next)02-17
Inst Owners83.09%
Inst Owner Change-2.62%
Ins Owners5.89%
Ins Owner Change4.96%
Market Cap516.45M
Revenue(TTM)119.55M
Net Income(TTM)-10.49M
Analysts81.82
Price Target18.16 (0.11%)
Short Float %2.15%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield 11.14%
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-507.68%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.89%
Min EPS beat(2)-88.54%
Max EPS beat(2)-63.24%
EPS beat(4)0
Avg EPS beat(4)-63.43%
Min EPS beat(4)-88.54%
Max EPS beat(4)-43.98%
EPS beat(8)0
Avg EPS beat(8)-53.34%
EPS beat(12)1
Avg EPS beat(12)-60.44%
EPS beat(16)1
Avg EPS beat(16)-48.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.34%
Revenue beat(12)1
Avg Revenue beat(12)-2.84%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0%
PT rev (3m)-6.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.13%
Revenue NQ rev (3m)1.76%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.84
P/S 4.32
P/FCF N/A
P/OCF 9.13
P/B 1.21
P/tB 1.21
EV/EBITDA 14.63
EPS(TTM)-0.15
EYN/A
EPS(NY)0.48
Fwd EY2.64%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)1.99
OCFY10.96%
SpS4.2
BVpS14.99
TBVpS14.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.06%
ROE -2.46%
ROCE 2.88%
ROIC 2.27%
ROICexc 2.28%
ROICexgc 2.32%
OM 23.26%
PM (TTM) N/A
GM 80.68%
FCFM N/A
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexgc growth 3Y-9.66%
ROICexgc growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA 7.48
Cap/Depr 145.76%
Cap/Sales 53.07%
Interest Coverage 1.1
Cash Conversion 79.35%
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.16
Altman-Z 0.86
F-Score3
WACC6.8%
ROIC/WACC0.33
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
Revenue Next Year5.07%
Revenue Next 2Y5.72%
Revenue Next 3Y6.67%
Revenue Next 5Y9.35%
EBIT growth 1Y-32.49%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year265.38%
EBIT Next 3Y62.68%
EBIT Next 5YN/A
FCF growth 1Y92.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.45%
OCF growth 3Y1.48%
OCF growth 5Y12.72%

COMMUNITY HEALTHCARE TRUST I / CHCT FAQ

What is the fundamental rating for CHCT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHCT.


What is the valuation status for CHCT stock?

ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.


What is the profitability of CHCT stock?

COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 3 / 10.


Can you provide the financial health for CHCT stock?

The financial health rating of COMMUNITY HEALTHCARE TRUST I (CHCT) is 1 / 10.